Tatiana Carreno-Galeano

Bevacizumab in High-Risk Corneal Transplantation: a Pilot Multi-Center Prospective Randomized Control Trial.

R. Dana, V. Perez, S. Yoo, 2022, Ophthalmology.

Suppression of Neovascularization by Topical and Subconjunctival Bevacizumab After High-Risk Corneal Transplantation

J. Ciolino, P. Hamrah, A. Di Zazzo, 2024, Ophthalmology science.